Vis enkel innførsel

dc.contributor.authorMohn, Kristin Greve-Isdahl
dc.contributor.authorBredholt, Geir
dc.contributor.authorZhou, Fan
dc.contributor.authorMadsen, Anders Aasgaard
dc.contributor.authorOnyango, Therese Bredholt
dc.contributor.authorFjelltveit, Elisabeth Berg
dc.contributor.authorJalloh, Sarah Larteley Lartey
dc.contributor.authorBrokstad, Karl Albert
dc.contributor.authorCantoni, Diego
dc.contributor.authorMayora-Neto, Martin
dc.contributor.authorTemperton, Nigel
dc.contributor.authorLangeland, Nina
dc.contributor.authorCox, Rebecca Jane
dc.date.accessioned2022-06-08T08:12:38Z
dc.date.available2022-06-08T08:12:38Z
dc.date.created2022-05-24T12:52:11Z
dc.date.issued2022
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/11250/2997822
dc.description.abstractBackground Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 virus, and long-term memory responses determine the risk of re-infection or boosting after vaccination. T-cellular responses are considered important for partial protection against novel variants of concern. Methods A prospective cohort of hospitalized (n = 14) and community (n = 38) patients with rt-PCR confirmed SARS-CoV-2 infection were recruited. Blood samples and clinical data were collected when diagnosed and at 6 months. Serum samples were analyzed for SARS-CoV-2-spike specific antibodies using ELISA (IgG, IgA, IgM), pseudotype neutralization and microneutralization assays. Peripheral blood mononuclear cells were investigated for virus-specific T-cell responses in the interferon-γ and interleukin-2 fluorescent-linked immunosorbent spot (FluroSpot) assay. Results We found durable SARS-CoV-2 spike- and internal protein specific T-cellular responses in patients with persistent antibodies at 6 months. Significantly higher IL-2 and IFN-γ secreting T-cell responses as well as SARS-CoV-2 specific IgG and neutralizing antibodies were detected in hospitalized compared to community patients. The immune response was impacted by age, gender, comorbidity and severity of illness, reflecting clinical observations. Conclusions SARS-CoV-2 specific T-cellular and antibody responses persisted for 6 months post confirmed infection. In previously infected patients, re-exposure or vaccination will boost long-term immunity, possibly providing protection against re-infection with variant viruses.en_US
dc.language.isoengen_US
dc.publisherPLOSen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleDurable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patientsen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.source.articlenumbere0261979en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1371/journal.pone.0261979
dc.identifier.cristin2026948
dc.source.journalPLOS ONEen_US
dc.identifier.citationPLOS ONE. 2022, 17 (2), e0261979.en_US
dc.source.volume17en_US
dc.source.issue2en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal